Evidence map›Paper›PMID 40424373›Full record

ArticlePloS one2025

Lightweight wavelet-CNN tea leaf disease detection.

Jing Yang, GaoJian Xu, MengDao Yang, ZhengPei Lin

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jing YangSchool of Information and Artificial Intelligence, Anhui Agricultural University, Hefei, Anhui, China.ORCID https://orcid.org/0009-0008-0107-6636
GaoJian XuSchool of Information and Artificial Intelligence, Anhui Agricultural University, Hefei, Anhui, China.ORCID https://orcid.org/0009-0009-5141-424X
MengDao YangSchool of Information and Artificial Intelligence, Anhui Agricultural University, Hefei, Anhui, China.
ZhengPei LinSchool of Information and Artificial Intelligence, Anhui Agricultural University, Hefei, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tea diseases can significantly impact crop yield and quality, necessitating accurate and efficient recognition methods. This study presents WaveLiteNet, a lightweight model designed for tea disease recognition, addressing the challenge of inadequate disease feature extraction in existing approaches. By integrating 2D discrete wavelet transform (DWT) with MobileNetV3, the model enhances noise suppression and feature extraction through an adaptive thresholding strategy in the 2D DWT. The extracted frequency-domain features are fused with depth features from the Bneck structure, enabling a more comprehensive representation of disease characteristics. To further optimize feature extraction, a convolutional block attention module (CBAM) is incorporated within the Bneck structure, refining the network's ability to assign optimal weights to feature channels. A focal loss function also replaces traditional cross-entropy loss to mitigate sample category imbalance, improving recognition accuracy across varying distributions. Experimental results show that WaveLiteNet achieves a 98.70% recognition accuracy on five types of tea leaf diseases, with a parameter count of 3.16 × 10⁶. Compared to MobileNetV3, this represents a 2.15 percentage point improvement in accuracy while reducing the parameter count by 25.12%. These findings underscore WaveLiteNet's potential as a highly efficient and lightweight real-time crop disease recognition solution, particularly in resource-constrained agricultural environments.

Indexed as

Camellia sinensisNeural Networks, ComputerPlant DiseasesPlant LeavesTeaWavelet AnalysisAlgorithmsTea

Identifiers

PMID40424373
PMCPMC12112342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.